ML20199B238
| ML20199B238 | |
| Person / Time | |
|---|---|
| Issue date: | 12/30/1997 |
| From: | Kinneman J NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION I) |
| To: | Raig W AFFILIATION NOT ASSIGNED |
| Shared Package | |
| ML20199B240 | List: |
| References | |
| NUDOCS 9801280211 | |
| Download: ML20199B238 (3) | |
Text
.< ',
E ,
DEC 30 }gg7 Wendi D. Raig, Radiation Safety Officer Triangle Pharmaceuticals 4 University Place 4611 University Drive Durham, North Carolina 27707
Dear Ms. Raig:
This refers to your letter 'eceived by facsimile on December 11,1997 requesting confirmation of your understanding of distribution of exempt quantitles of licensed material. It also refers to the telephone conversations un December 10 and 11,1997, between you and Betsy Ullrich and Richard Gibson of this office regarding transfer of exempt quantities of licensed material. We understand that you are a licensee of the State of North Carolina, and wish to send samples labelled wi,th carbon-14 to collaborators in an NRC reguland state in Region 1. As a state licensee, you should contact the State of North Carolina to be sure that you are in compliance with the state regulations.
Your understanding of the NRC regulations concerning distribution of exempt quantitles, as documented in your letter, are correct. As discussed with you during the telephone conversations, in accordance with the NRC regulations found in Title 10, Code of Federal Regulations, Part 30.18 (10 CFR 30.18) " Exempt Quantitles", any person is exempt from the requirements for a license to the extent tha'. the person receives, possess, uses, transfers, owns, or acquires byproduct materials in individual quantities which do not exceed the applicable quantity listed in 10 CFR 30.71, Schedule B. The applicable quantity for carbon-14 is 100 microcuries.10 CFR 30.18(c) and (d) prohibits commercial distribution of such exempt quantities, unless the distributor is authorized pursuant to 10 CFR 32.18 for commercial distribution of e exempt quantities. Therefore, you may send labelled samples to a collaborator, and they may receive the samples, if the indi/idual quantities are less than 100 microcuries and if this is not a commercial distribution.
I lblV 28ooea ll!]Igllilll;llgil,1lll-
. . . . OFFICIAL RECORD COPY
'- '9901290211 971230
-PDR STPRG ESONC
, PDR g
.. . . . . . . - _ . - . - . . - , . . . . . . - . - - . - - . . . - . - ~ . - . . . . ~ . . .
G- ..
Triangle Pharmaceuticals 2 If you have any additional questions, we will be pleased to discuss them with you. ,
~ Sincerely, f'
ORIGINAL SIGNED BY: ;
John D. Kinneman, Chief Nuclear Materials Safety Branch 2 Division of Nuclear Materials Safety '
Enclosures:
10 CFR Parts 30 and 32 cc:
- State of North Carolina e
4
. OFFICIAL RECORD COPY -
l l
I -
c' ,
W. Held 3 Triangle Pharrnaceuticals Distribution: (w/o encl)
Region i Docket Room (w/coticurrences) o DOCUMENT NAME: R:\WAS\ MISC \ TRIANGLE, EMU To tweelve e copy of todo document. indicals h the boa: 'C' Copy w/o attach / enc *t' = Copy w/ ettschienc 'N' = No copy OFFICE DAMJyff lN $P.}$6tl ld l l NAME ULLR @ermu vi4EMAN DATE 12/22/97 12/vy97 12/ /97 - 12/ /97 me OFFICIAL RECORD COPY